Marina Chiara Garassino

2 ta ish

Fondazione IRCCS Istituto Nazionale dei Tumori

1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

   Julie R. Brahmer, Karen L. Reckamp, Paul Baas +22

   MaqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.170111

2. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

   Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel +26

   MaqolaOAOchiq kirish20182 iqtibos

   ABIABI:AkademIndex/2026.other.097054